Abstract
Lidocaine has been used to treat neuropathic pain by virtue of its ability to block sodium channels and thus block neuropathic pain signaling. On the theory that migraines or other pain syndromes may also be neuropathically mediated, we tried treatment of refractory migraines and pain with this agent in the clinic. 64 patients were treated (49 female/15 male) [average age 40.8 yrs] for refractory headaches and pain in the clinic. An IV line was started with pulse oximetry monitoring. Patients had failed at-home treatment for their pain/migraines.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
